Skip to main content

Peer Review reports

From: Levocetrizine attenuates cyclophosphamide-induced lung injury through inhibition of TNF-α, IL-1β, TGF-β and MMP-9

Original Submission
22 Aug 2023 Submitted Original manuscript
8 Sep 2023 Author responded Author comments - Dalia H. El-Kashef
Resubmission - Version 2
8 Sep 2023 Submitted Manuscript version 2
4 Oct 2023 Reviewed Reviewer Report
16 Oct 2023 Reviewed Reviewer Report
7 Nov 2023 Author responded Author comments - Dalia H. El-Kashef
Resubmission - Version 3
7 Nov 2023 Submitted Manuscript version 3
8 Nov 2023 Author responded Author comments - Dalia H. El-Kashef
Resubmission - Version 4
8 Nov 2023 Submitted Manuscript version 4
14 Nov 2023 Reviewed Reviewer Report
18 Nov 2023 Reviewed Reviewer Report
28 Nov 2023 Author responded Author comments - Dalia H. El-Kashef
Resubmission - Version 5
28 Nov 2023 Submitted Manuscript version 5
Publishing
30 Nov 2023 Editorially accepted
11 Dec 2023 Article published 10.1186/s40360-023-00717-3

You can find further information about peer review here.

Back to article page